Immunoglobulin G subclass response to a meningococcal quadrivalent polysaccharide-diphtheria toxoid conjugate vaccine

Clinical and Vaccine Immunology

Volumn 13, Issue 4, 2006, Pages 507-510

  Findlow, Helen ^a   Southern, Jo ^a   Mabey, Lesley ^a   Balmer, Paul ^a   Heyderman, Robert S ^b,d   Auckland, Cressida ^a   Morris, Rhonwen ^c   Miller, Elizabeth ^a   Borrow, Ray ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c Gloucester Vaccine Evaluation Unit   (United Kingdom)

^d Bristol HPA Laboratory   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA VACCINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; MENINGOCOCCUS VACCINE; POLYSACCHARIDE VACCINE;

ADULT; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BLOOD SAMPLING; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; MALE; MENINGOCOCCOSIS; NORMAL HUMAN; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; SERUM BACTERICIDAL ACTIVITY; T LYMPHOCYTE ACTIVATION; VACCINATION;

ADULT; ANTIBODIES, BACTERIAL; BLOOD BACTERICIDAL ACTIVITY; DIPHTHERIA TOXOID; HUMANS; IMMUNOGLOBULIN G; MENINGOCOCCAL VACCINES; MIDDLE AGED; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; VACCINES, CONJUGATE;

EID: 33745909425     PISSN: 15566811     EISSN: None     Source Type: Journal    
DOI: 10.1128/CVI.13.4.507-510.2006     Document Type: Article

References (20)

1. Andrews, N., R. Borrow, and E. Miller. 2003. Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin. Diagn. Lab. Immunol. 10:780-786.
2. Bilukha, O. O., and N. E. Rosenstein. 2005. Prevention and control of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly. Rep. 54:1-21.
3. Borrow, R., N. Andrews, D. Goldblatt, and E. Miller. 2001. Serological basis for the use of meningococcal serogroup C conjugate vaccines in the United Kingdom: reevaluation of the correlates of protection. Infect. Immun. 69:1568-1573.
4. Campbell, J. D., R. Edelman, J. C. King, Jr., T. Papa, R. Ryall, and M. B. Rennels. 2002. Safety, reactogenicity, and immunogenicity of a tetravalent meningococcal polysaccharide-diphtheria toxoid conjugate vaccine given to healthy adults. J. Infect. Dis. 186:1848-1851.
5. Carlone, G. M., C. E. Frasch, G. R. Siber, S. Quataert, L. L. Gheesling, S. H. Turner, B. D. Pilkaytis, L. O. Helsel, W. E. DeWitt, W. F. Bibb, B. Swaminthan, G. Arakere, C. Thompson, D. Phipps, D. Madore, and C. V. Broome. 1992. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A polysaccharide measured by using an enzyme-linked immunosorbent assay. J. Clin. Microbiol. 30:154-159.
6. Goldblatt, D., R. Borrow, and E. Miller. 2002. Natural and vaccine-induced immunity and immunologic memory to Neisseria meningitidis serogroup C in young adults. J. Infect. Dis. 185:397-400.
7. Holder, P. K., S. E. Maslanka, L. B. Pais, J. Dykes, B. D. Plikaytis, and G. M. Carlone. 1995. Assignment of Neisseria meningitidis serogroup A and C class-specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin. Diagn. Lab. Immunol. 2:132-137.
8. Huo, Z., R. Sinha, E. A. McNeela, R. Borrow, R. Giemza, C. Cosgrove, P. T. Heath, K. H. Mills, R. Rappuoli, G. E. Griffin, and D. J. Lewis. 2005. Induction of protective serum meningococcal bactericidal and diphtheria-neutralizing antibodies and mucosal immunoglobulin A in volunteers by nasal insufflations of the Neisseria meningitidis serogroup C polysaccharide-CRM197 conjugate vaccine mixed with chitosan. Infect. Immun. 73:8256-8265.
9. Insel, R. A., and P. W. Anderson. 1986. Response to oligosaccharide- protein conjugate vaccine against Haemophilus influenzae b in two patients with IgG2 deficiency unresponsive to capsular polysaccharide vaccine. N. Engl. J. Med. 315:499-503.
10. Joseph, H., P. Balmer, M. Bybel, T. Papa, R. Ryall, and R. Borrow. 2004. Assignment of Neisseria meningitidis serogroups A, C, W135, and Y anticapsular total immunoglobulin G (IgG), IgG1, and IgG2 concentrations to reference sera. Clin. Diagn. Lab. Immunol. 11:1-5.
11. Keyserling, H., T. Papa, K. Koranyi, R. Ryall, E. Bassily, M. J. Bybel, K. Sullivan, G. Gilmet, and A. Reinhardt. 2005. Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents. Arch. Pediatr. Adolesc. Med. 159:907-913.
12. Lottenbach, K. R., C. M. Mink, S. J. Barenkamp, E. L. Anderson, S. M. Homan, and D. C. Powers. 1999. Age-associated differences in immunoglobulin G1 (IgG1) and IgG2 subclass antibodies to pneumococcal polysaccharides following vaccination. Infect. Immun. 67:4935-4938.
13. Maclennan, J., S. Obaro, J. Deeks, D. Lake, C. Elie, G. Carlone, E. R. Moxon, and B. Greenwood. 2001. Immunologic memory 5 years after meningococcal A/C conjugate vaccination in infancy. J. Infect. Dis. 183:97-104.
14. Maslanka, S. E., L. L. Gheesling, D. E. Libutti, K. B. Donaldson, H. S. Harakeh, J. K. Dykes, F. F. Arhin, S. J. Devi, C. E. Frasch, J. C. Huang, P. Kriz-Kuzemenska, R. D. Lemmon, M. Lorange, C. C. Peeters, S. Quataert, J. Y. Tai, G. M. Carlone, et al. 1997. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. Clin. Diagn. Lab. Immunol. 4:156-167.
15. Oxelius, V. A. 1979. IgG subclass levels in infancy and childhood. Acta Paediatr. Scand. 68:23-27.
16. Pichichero, M., J. Casey, M. Blatter, E. Rothstein, R. Ryall, M. Bybel, G. Gilmet, and T. Papa. 2005. A comparative trial of the safety and immunogenicity of quadrivalent (A, C, Y, W-135) meningococcal polysaccharide-diphtheria conjugate vaccine versus quadrivalent polysaccharide vaccine in two ten-year-old children. Pediatr. Infect. Dis. J. 24:57-62.
17. Rautonen, N., J. Pelkonen, S. Sipinen, H. Kayhty, and O. Makela. 1986. Isotype concentrations of human antibodies to group A meningococcal polysaccharide. J. Immunol. 137:2670-2675.
18. Robbins, J., L. Myerowitz, J. K. Whisnant, M. Argaman, R. Schneerson, Z. T. Handzel, and E. C. Gotschlich. 1972. Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3. Infect. Immun. 6:651-656.
19. Sikkema, D. J., N. A. Ziembiec, T. R. Jones, S. W. Hildreth, D. V. Madore, and S. A. Quataert. 2005. Assignment of weight-based immunoglobulin G1 (IgG1) and IgG2 units in antipneumococcal reference serum lot 89-S(F) for pneumococcal polysaccharide serotypes 1, 4, 5, 7F, 9V, and 18C. Clin. Diagn. Lab. Immunol. 12:218-223.
20. Soininen, A., I. Seppala, T. Nieminen, J. Eskola, and H. Kayhty. 1999. IgG subclass distribution of antibodies after vaccination of adults with pneumococcal conjugate vaccines. Vaccine 17:1889-1897.